Pacific Biosciences of California Inc. Common Stock (PACB)

About PACB

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library forma…

Sector

Industrials

Industry

Biotechnology: Laboratory Analytical Instruments

Employees

485

Website

www.pacb.com/

Fundamentals

1-day range

$1.39$1.55

Market cap

$441.05M

P/E (trailing)

—

P/E (forward)

-3.46

EPS (trailing)

$-0.43

Dividend yield

—

Beta

2.33

Avg. volume

6.73M

Forecasts

6 analyst ratings

Pacific Biosciences of California Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• PACB

  Pacific Biosciences of California Inc. Common Stock

  $1.4

  ▼ 10.00%
  Market cap $441.05MP/E —
  $1.07$2.73
• LAB

  Standard BioTools Inc. Common Stock

  $0.64

  ▼ 1.54%
  Market cap $339.09MP/E 3.47
  $0.6251$1.72
• CTKB

  Cytek Biosciences Inc. Common Stock

  $4.69

  ▲ 1.41%
  Market cap $556.60MP/E —
  $3.28$6.18
• NAUT

  Nautilus Biotechnology Inc. Common Stock

  $0.8828

  ▼ 2.35%
  Market cap $128.53MP/E —
  $0.62$4.31
• RPID

  Rapid Micro Biosystems Inc. Class A Common Stock

  $1.56

  ▼ 3.11%
  Market cap $97.88MP/E —
  $1.52$4.94
• CIRC

  Circle8 Group Inc. Common Stock

  $0.7246

  ▲ 2.34%
  Market cap $60.19MP/E —
  $0.4773$0.98
• PRPO

  Precipio Inc. Common Stock

  $28.85

  ▼ 1.50%
  Market cap $39.55MP/E —
  $14.28$33.63

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday
  Benzinga · 8/25/2026
• PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity
  Yahoo · 8/16/2026
• 5 Must-Read Analyst Questions From PacBio’s Q2 Earnings Call
  Yahoo · 8/14/2026
• Pacific Biosciences of California, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/8/2026
• PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut
  Yahoo · 8/6/2026
• Pacific Biosciences of California Q2 Earnings Call Highlights
  Yahoo · 8/6/2026
• Pacific Biosciences: It's Only Getting Worse
  SeekingAlpha · 8/6/2026
• Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026

• Van Oene Mark · August 10, 2026 · Grant

  1.97M
• Van Oene Mark · August 10, 2026 · Grant

  489.1K
• Christopher Gibson · June 3, 2026 · Grant

  74.5K
• Smith Christopher M · June 3, 2026 · Grant

  223.5K
• Hannah Valantine · June 3, 2026 · Grant

  223.5K
• Ericson William W. · June 3, 2026 · Grant

  223.5K
• Marshall Mohr · June 3, 2026 · Grant

  223.5K
• LIVINGSTON RANDALL S · June 3, 2026 · Grant

  223.5K
• ORDONEZ KATHY · June 3, 2026 · Grant

  223.5K
• MILLIGAN JOHN F · June 3, 2026 · Grant

  223.5K
• Christopher Gibson · April 8, 2026 · Grant

  77.8K
• Christopher Gibson · April 8, 2026 · Grant

  57.5K
• Gibson James R II · April 1, 2026 · Sale

  88.2K @ $1.37
• Christopher Gibson · March 3, 2026 · Grant

  73.1K
• Christopher Gibson · March 3, 2026 · Grant

  53.9K

Institutional Ownership

March 31, 2026

Total shares held

184.28M

Total value held

$240.66M

Institutional holders

225